Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03489369
What this trial is testing

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

Who this might be right for
Metastatic CancerSolid TumorLymphoma
Symphogen A/S 15
Early research (Phase 1)Study completedNCT02814656
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 24
Large-scale testing (Phase 3)Ended earlyNCT00668772
What this trial is testing

Tiotropium/Salmeterol Inhalation Powder in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 207
Large-scale testing (Phase 3)Study completedNCT02629965
What this trial is testing

Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 184
Large-scale testing (Phase 3)Study completedNCT02345226
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 881
Early research (Phase 1)Study completedNCT01800240
What this trial is testing

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions

Who this might be right for
Healthy
Torrent Pharmaceuticals Limited
Not applicableLooking for participantsNCT06259162
What this trial is testing

LAG3 Expression in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerImmune Checkpoint Inhibitor
Samsung Medical Center 128
Early research (Phase 1)Active Not RecruitingNCT04658147
What this trial is testing

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Early research (Phase 1)Study completedNCT02821910
What this trial is testing

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 50
Testing effectiveness (Phase 2)Study completedNCT00312091
What this trial is testing

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)Study completedNCT02184585
What this trial is testing

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 84
Not applicableStudy completedNCT03038789
What this trial is testing

XIGDUO Extended Release (XR) Post Marketing Surveillance

Who this might be right for
Adult Patients With Type 2 Diabetes Mellitus
AstraZeneca 623
Early research (Phase 1)Study completedNCT03272425
What this trial is testing

Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

Who this might be right for
Gout
Ardea Biosciences, Inc. 32
Not applicableStudy completedNCT05160974
What this trial is testing

QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 679
Early research (Phase 1)Study completedNCT00556920
What this trial is testing

Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components

Who this might be right for
Hypertension
GlaxoSmithKline 50
Early research (Phase 1)Not Yet RecruitingNCT06691360
What this trial is testing

AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 87
Testing effectiveness (Phase 2)Looking for participantsNCT06918132
What this trial is testing

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more
Mayo Clinic 60
Not applicableStudy completedNCT05138523
What this trial is testing

Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)

Who this might be right for
Chronic Hepatitis c
Beker Laboratories 99
Not applicableStudy completedNCT05346276
What this trial is testing

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

Who this might be right for
PET/CThLAG-3TUMOR
The First Affiliated Hospital of Xiamen University 50
Large-scale testing (Phase 3)Study completedNCT02924688
What this trial is testing

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

Who this might be right for
Asthma
GlaxoSmithKline 2,436
Next Page